FrangouGroup
FrangouGroup

2013

Dima D, Jogia J, Collier D, Vassos E, Burdick KE, Frangou S. CACNA1C and ANK3 risk-genes for bipolar disorder independently modulate engagement and connectivity of the face network during affect processing. JAMA Psychiatry. 2013;70 (12):1303-11. PMID: 24108394

 

Frangou S. Snipping at the endophenotypic space. Am J Psychiatry. 2013; 170(11): 1223-5. PMID: 24185234

 

Papachristou E, Ormel J, Oldehinkel AJ, Kyriakopoulos M, Reinares M, Reichenberg A, Frangou S. Child Behavior Checklist—Mania Scale (CBCL-MS): Development and Evaluation of a Population-Based Screening Scale for Bipolar Disorder. PLoS ONE 8(8): e69459 PMID: 23967059

 

Papachristou E, Frangou S, Reichenberg A. Expanding conceptual frameworks: Life course risk modelling for mental disorders. Psychiatry Res 206(2-3):140-5. PMID: 23127538

 

Frangou S. Neurocognition in early-onset schizophrenia. Child Adolesc Psychiatr Clin N Am. 2013;22(4):715-26. PMID: 24012082

 

Delvecchio G, Sugranyes G, Frangou S. Evidence of diagnostic specificity in the neural correlates of facial affect processing in bipolar disorder and schizophrenia: a meta-analysis of functional imaging studies. Psychol Med. 2013; 43(3):553-69. PMID: 22874625



Brambilla P, Perlini C, Bellani M, Tomelleri L, Ferro A, Cerruti S, Marinelli V, Rambaldelli G, Christodoulou T, Jogia J, Dima D, Tansella M, Balestrieri M,  Frangou S. Increased salience of gains versus decreased associative learning differentiate bipolar disorder from schizophrenia during incentive decision making. Psychol Med. 2013; 43(3):571-80. PMID: 22687364



Reinares M, Papachristou E, Harvey P, Mar Bonnín C, Sánchez-Moreno J, Torrent C, Ayuso-Mateos JL, Ploubidis GB, Vieta E, Frangou S. Towards a clinical staging for bipolar disorder: Defining patient subtypes based on functional outcome. J Affect Disord. 2013; 144(1-2):65-71.

 

Reinares M, Rosa AR, Franco C, Goikolea JM, Fountoulakis K, Siamouli M, Gonda X, Frangou S, Vieta E. A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression. Int J Neuropsychopharmacol. 2013;16(2):485-96. PMID: 22575611

 

Cheema N, Frangou S, McCrone P. Cost-effectiveness of ethyl-eicosapentaenoic acid in the treatment of bipolar disorder. Ther Adv Psychopharmacol. 2013;3(2):73-81. PMID: 24167678

 

Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA, Leboyer M, Berk M, Malhi GS, Lopez-Jaramillo C, Taylor VH, Dodd S, Frangou S, Hall GB, Fernandes BS, Kauer-Sant'anna M, Yatham LN, Kapczinski F, Young LT. Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry 47(4):321-32. PMID: 23411094



Latest Publication

Visitors Count

 

To learn more about our research or to participate in our studies email us at

 

prp@mssm.edu

 

or call us on

 

212 659 1668

 

Print Print | Sitemap
© FrangouGroup

This website was created using 1&1 MyWebsite.